A novel gyrase inhibitor for the treatment of drug-susceptible and multidrug-resistant mycobacterium tuberculosis infections
Ended Project Grant Awarded Last action
- Award ID
- R44AI131749
- Recipient
-
Spero Legacy Sti, Inc. UEI VV22G4K3AZC4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $989,738
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Place of performance
- Cambridge, MA 02139, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$158 | |
| Amendment | $0 | |
| Amendment | $425,178 | |
| Original award | $564,718 |
Quick answers
Who received award R44AI131749?
R44AI131749 was awarded to Spero Legacy Sti, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on March 1, 2017.
How much is award R44AI131749 worth?
$989,738 has been obligated on R44AI131749.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award